Ana I Flores
Grupo de Medicina Regenerativa, Centro de Investigación Instituto de Investigación Hospital, Spain
Dr. Ana I. Flores received her undergraduate degree from the Pharmacy School at the Universidad of Salamanca, Spain. She joined the Centro de Biología Molecular Severo Ochoa (CBMSO) and obtained her PhD degree from the School of Chemistry of the Universidad Autónoma de Madrid. She received the Doctoral Thesis Award. She completed her postdoctoral studies in the United States in the Department of Physiology and Biophysics, Case Western Reserve University and in the Department of Neurosciences at the Lerner Research Institute of the Cleveland Clinic Foundation, both institutions in Cleveland, Ohio. During her postdoctoral training at the Cleveland Clinic, she was awarded with a postdoctoral fellowship from the National Multiple Sclerosis Society and the Travel Award 2001 Dale McFarlin from the same society. In 2004, she joined the Hospital Universitario 12 de Octubre in Madrid as the Principal Investigator of the Regenerative Medicine Group. Since then, Dr. Flores had been focused on the isolation and characterization of placental mesenchymal stem/stromal cells from maternal origin, i.e., the decidua. She is interested in the characterization of their biology and their therapeutic effect in several diseases, such as cancer, neurodegeneration, hemophilia, hearing loss and pelvic floor and bone pathologies. The cells could serve as therapeutic agents themselves and as cellular vehicles. Dr. Flores received an award by Diario Medico, an important Medical Journal in Spain, which recognized the article "Mesenchymal stem cells from human placenta" as “One of the Best Ideas in Health from the Year 2010" in the area of Research and Pharmacology. Dr. Flores has been member of Biobank Scientific Committee from Hospital 12 de Octubre and member of its Evaluation Subcommittee from 2013 to 2016. From the beginning of 2017, she is Director of Biobank Scientific Committee and member of its Evaluation Subcommittee. Dr. Flores also collaborates as an external reviewer of proposals submitted to both, national agencies and European Research Council.
Focused on the isolation and characterization of placental mesenchymal stem/stromal cells from maternal origin, i.e., the decidua. She is interested in the characterization of their biology and their therapeutic effect in several diseases, such as cancer, neurodegeneration, hemophilia, hearing loss and pelvic floor and bone pathologies.
Journal of Tissue Science and Engineering received 807 citations as per Google Scholar report